Managing pollen asthma with a single inhaler: a case study

According to the definition proposed by the global leadership of GINA (Global Initiative for Asthma) in 2014, asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation. [1].

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - year:2015

Enthalten in:

Медицинский совет - (2015), 11, Seite 36-41

Sprache:

Russisch

Beteiligte Personen:

N. M. Nenasheva [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.med-sovet.pro [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

будесонид/формотерол
пыльцевая бронхиальная астма
симбикорт
Budesonide/formoterol
Medicine
Pollen asthma
R
Symbicort

doi:

10.21518/2079-701X-2015-11-36-41

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ078829119